Shikiar Asset Management Inc. significantly reduced its stake in Salesforce Inc. by 50.9% in the first quarter, selling 15,260 shares but still retaining 14,707 shares valued at $2.75 million. This move comes as Salesforce reported strong quarterly results, beating EPS and revenue estimates, and raising future guidance. The company is actively engaged in shareholder-return initiatives, including a $25 billion share repurchase program and a quarterly dividend, while maintaining a "Moderate Buy" consensus analyst rating.

SMART Wealth LLC has initiated a new position in Analog Devices, Inc. (NASDAQ:ADI), purchasing 7,277 shares valued at approximately $2.315 million in the first quarter, contributing to institutional investors owning 86.81% of the company. Analog Devices reported strong quarterly results, beating EPS and revenue estimates, with significant year-over-year revenue growth and positive Q3 guidance. Wall Street maintains a "Moderate Buy" rating with a consensus price target of $439.79, and the company offers a quarterly dividend.

RBC Capital has downgraded Dow Inc. (DOW) from Outperform to Sector Perform and reduced its price target from $51 to $28 due to declining polyethylene prices, weak market demand, and significant investment in the Alberta cracker project. Dow's GF Score™ is 56/100, with a low financial strength of 4/10, indicating potential struggles with financial obligations and stability. The company faces challenges in profitability, reflected by negative earnings and the inapplicability of its P/E ratio.

Beta Bionics, Inc. (BBNX) Chief Financial Officer Stephen Feider sold 10,000 shares of common stock in open-market transactions between June 26 and June 29, 2026, at weighted average prices around $17.04. These sales were conducted under a pre-arranged Rule 10b5-1 trading plan adopted in May 2025, following the exercise of stock options for 9,878 shares at $5.10 each. Feider retained a significant equity position, directly holding 165,931 shares after these transactions.

This page provides financial information for BlackLine, Inc. (NASDAQ:BL), specifically focusing on its price-to-sales forward ratio. It displays the company's stock market data, indicating that the market is closed with no recent trades. The content also notes that the data is made by humans and offers various other financial tools and data from TradingView.

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against BellRing Brands, Inc. (NYSE: BRBR) and certain officers. The lawsuit alleges that BellRing made false and misleading statements about its sales, which the firm claims were due to customers accumulating excess inventory rather than genuine consumer demand. Investors who purchased BellRing securities between November 19, 2024, and August 4, 2025, are encouraged to join the lawsuit by March 23, 2026.

Analysts have provided insights on Truist Financial (TFC) and Robinhood (HOOD), both in the financial sector. Truist Financial received a Moderate Buy consensus with an 8.6% upside, while Robinhood secured a Strong Buy consensus with a 3.4% upside. Both reports highlight analyst ratings and price targets for these companies.

Black Rock Coffee Bar, Inc. (BRCB) is facing a securities class action lawsuit due to alleged misleading disclosures in its initial public offering documents. The lawsuit claims that the company failed to disclose that new store openings were leading to cannibalization of existing services, negatively impacting revenue growth. Following a Q1 2026 financial report revealing a significant decrease in same-store sales growth and the impact of "sales transfer," Black Rock Coffee's stock price dropped over 30%.

The article reports the filing of a Form 13D/A by CALCIMEDICA for the period ending June 30. It includes a financial update for CALCIMEDICA, showing a 4.36% increase. The content briefly lists various global financial market data but offers no further details on the Form 13D/A filing itself.

Beyond Meat's stock rallied on Tuesday after the company announced the launch of its Beyond Steak Filet product at Wegmans and H-E-B grocery stores. This move is part of the company's strategy to diversify its product lineup and distribution to boost slumping sales, which saw a 15% year-over-year decline in the first quarter to $58 million. The plant-based steak product, which is already the top-seller on Beyond Meat's e-commerce site, is an effort to improve the company's financial performance.